Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

HIV

This page shows the latest HIV news and features for those working in and with pharma, biotech and healthcare.

ViiV’s two-drug HIV combo backed by CHMP

ViiV’s two-drug HIV combo backed by CHMP

ViiV’ s two-drug HIV combo backed by CHMP. The committee also backs two biosimilar medicines. ... pill, two-drug regimen with the opportunity to reduce the number of drugs needed to treat HIV”.

Latest news

  • Long-serving R&D head Bischofberger to leave Gilead Long-serving R&D head Bischofberger to leave Gilead

    During his tenure he oversaw the launch of a raft of HIV and hepatitis C and B therapies. ... Meanwhile Cheng has worked at the biotech since 1999 - coming from the University of California, Los Angeles - and has focused primarily on leading company’s

  • Theratechnologies’ last-ditch HIV drug approved by FDA Theratechnologies’ last-ditch HIV drug approved by FDA

    Theratechnologies’ last-ditch HIV drug approved by FDA. The injectable becomes an add-on treatment for patients who have previously taken ART. ... An antibody drug that will provide a new treatment option for people with multidrug-resistant HIV has

  • Gilead says switching studies back new HIV therapy Biktarvy Gilead says switching studies back new HIV therapy Biktarvy

    Gilead says switching studies back new HIV therapy Biktarvy. Patients who switched from rival Triumeq could maintain viral suppression over the trial period. ... Both Biktarvy and Triumeq are fixed-dose triple therapies for HIV delivered once-daily, and

  • Gilead study resurrects HIV eradication hope Gilead study resurrects HIV eradication hope

    Gilead study resurrects HIV eradication hope. Intends to start human trials of its improved bNAb candidate. ... In some cases, the infected animals showed a rebound but began re-suppressing HIV without the need for ART.

  • Gilead’s triple HIV drug approval prompts GSK lawsuit Gilead’s triple HIV drug approval prompts GSK lawsuit

    Gilead’ s triple HIV drug approval prompts GSK lawsuit. ViiV claims bictegravir infringes its patent estate. ... The US FDA approved Gilead Sciences’triple-drug Biktarvy product for HIV this week, but the company’s celebrations were swiftly

More from news
Approximately 76 fully matching, plus 524 partially matching documents found.

Latest Intelligence

  • The cultural construction of illness The cultural construction of illness

    We once worked with a team marketing a product for people with HIV. ... Their advertising was failing to cut through and it became clear to us that one of the reasons for this was its depiction of happy, calm people living with HIV, but

  • Not dying of ignorance - 30 years on Not dying of ignorance - 30 years on

    Not dying of ignorance - 30 years on. Behavioural changes with HIV and AIDS. ... And EastEnders character Mark Fowler coming out as HIV positive had a massive impact, resulting in thousands of people being tested.

  • Is it time we stopped talking about adherence? Is it time we stopped talking about adherence?

    The EarthWorks has employed this philosophy to develop award-winning patient support programmes in chronic conditions such as asthma and HIV, and rare, complex conditions such as pulmonary arterial hypertension.

  • Healthcare Heroes Healthcare Heroes

    Back in 1982 while working in the Caribbean, Marc heard about a disease called HIV and how the misuse of syringes was transmitting the disease.

  • Deal Watch August 2016 Deal Watch August 2016

    469. Genmab (DK). Gilead (US). Licence. DuoBody technology platform to develop bispecific antibody candidates for targeting HIV plus option to second licence.

More from intelligence
Approximately 2 fully matching, plus 37 partially matching documents found.

Latest appointments

  • Aelix Therapeutics appoints Dr Thomas Hecht Aelix Therapeutics appoints Dr Thomas Hecht

    its HIV vaccine. ... After decades of work to develop a HIV vaccine, I hope to contribute with my experience in building a strong player that I believe has good chances to be amongst the

  • emotive boosts its client services team emotive boosts its client services team

    Fay Lepley also joins the agency as an account executive and has had experience working in PR and healthcare communications across several therapy areas including cardiovascular, diabetes and HIV.

  • GSK's Deborah Waterhouse to take over from ViiV' Dominique Limet GSK's Deborah Waterhouse to take over from ViiV' Dominique Limet

    GSK's Deborah Waterhouse to take over from ViiV' Dominique Limet. She will become CEO designate at the HIV-focused firm in January. ... GlaxoSmithKline has promoted Deborah Waterhouse to replace ViiV Healthcare's CEO Dominique Limet when he steps down

  • Bionor names executive management team additions Bionor names executive management team additions

    HIV and deadly virus firm Bionor Pharma has revealed a number of new additions to its executive management team. ... Together, they bring a wealth of experience to advance therapeutic vaccines for Bionor, and specifically will add operational strength to

  • MHP Health strengthens team with four hires MHP Health strengthens team with four hires

    She also volunteers for two HIV charities: one based in London, which supports young people who have family members affected by HIV and one that supports the work of people in

More from appointments
Approximately 1 fully matching, plus 13 partially matching documents found.

Latest from PMHub

  • Marketing strategy in complex environments

    Another popular combination therapy is  HAART: Highly Active Antiretroviral Therapy used for HIV where six major types of drugs are used.

  • Infographic: HIV Market Snapshot

    Infographic: HIV Market Snapshot. Our latest HIV infographic, taken from data collected from syndicated tracking study Therapy Watch, reveals that more than 3 in 5 naive or switch patients are currently ... Therapy Watch HIV patient data is collected

  • 90TEN Healthcare appointed to launch national STI service at Chelsea and Westminster

    Chelsea and Westminster Hospital NHS Foundation Trust, which runs the largest specialist HIV hub in Europe, has appointed 90TEN Healthcare to launch its new sexual health online-postal service. ... James Beckett, General Manager HIV/GUM, says: “ The

  • emotive. expands client services team

    HIV. Lizzie Nayman, Client Services Director for emotive. commented “ We are enjoying a very busy year at emotive.

  • Packer Forbes News May 2016

    Packer Forbes is delighted to have been awarded Silver in the category ‘ Digital Patient Initiatives’ at the prestigious PM Society Digital Awards; for the emotive and compelling film ‘ My HIV… My ... My HIV… My Rules’ was also a finalist in

More from PMHub
Approximately 3 fully matching, plus 26 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kantar Health

Kantar Health is a leading global healthcare consulting firm and trusted advisor to many of the world’s leading pharmaceutical, biotech,...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Quick links

Infographics

Multimedia